Skip to content

    Research Use Only

    This site is an independent educational resource for research compounds. We do not sell, distribute, or endorse human consumption of any compound. By entering, you confirm you are 21 years of age or older and agree to our Terms & Privacy Policy.

    🔬 100K+ researchers trust BodyHackGuide — Join r/BodyHackGuide
    AdaptogenPreclinical

    Panax ginseng Dosage Guide: Protocols, Calculator & Safety

    Everything you need to know about Panax ginseng dosing — protocols, safety, and where to buy.

    Dosage Calculator

    Calculate exact dosing for Panax ginseng.

    Dosing Protocols

    Beginner

    Beginner Protocol (new users, first 2-4 weeks):

    Start with 500 mg/day of Korean Red Ginseng (whole root powder) or 100-200 mg/day of standardized extract (G115 or equivalent at 4-5% ginsenosides) taken once daily with breakfast. This lower starting dose allows you to detect any sensitivity (insomnia, headache, GI upset, mild BP elevation) without confounding the signal. Take with breakfast, never in the evening — ginseng has mild stimulant-like effects that disrupt sleep in 5-10% of users who take it late.

    After 5-7 days at the starting dose with good tolerability, increase to 1,000 mg/day red root or 200-400 mg/day standardized extract for the first month. This dose is within the clinical range for most indications (ED, mild fatigue, cognitive support, general vitality) and allows the benefits to emerge over 2-4 weeks of consistent use.

    Expected response timeline: Subtle energy, cognitive clarity, and subjective well-being improvements often emerge within 1-2 weeks. Fatigue reduction and erectile function benefits take 4-8 weeks. Type 2 diabetes glucose effects take 8-12 weeks. Immune effects are indication-specific (prevention during cold/flu season, episodic for acute infection support).

    Brand recommendations for beginners:

    • Cheong Kwan Jang (Korea Ginseng Corp) — the Korean government-sanctioned KRG producer, widely considered the gold standard for Korean Red Ginseng. Available as extract powder, capsules, liquid, and traditional root. Higher priced but authentic, third-party-tested, and consistent quality.
    • Ginsana G115 (Pharmaton) — Swiss-produced standardized extract used in most Western clinical trials. 4% ginsenosides, widely available at pharmacies.
    • Nature's Way Korean Ginseng — budget-friendly KRG capsules with reasonable standardization.
    • NOW Korean Ginseng — standardized extract, good value for money, reliable manufacturer.

    Avoid unverified Amazon brands, bulk "Panax ginseng powder" without standardization, and products not specifying whether they are Panax ginseng or Panax quinquefolius (the latter is American ginseng with a different profile — see american ginseng).

    Standard

    Intermediate Protocol (established users, months 2-6):

    Standard clinical dose range: 1,000-3,000 mg/day of Korean Red Ginseng root (or 200-600 mg/day of G115-equivalent standardized extract). Most clinical trials have used 1-3 g/day KRG for fatigue, ED, and general vitality indications, with 3-9 g/day reserved for T2DM or more severe indications. Split dosing (500-1,500 mg with breakfast and 500-1,500 mg with lunch) can reduce peak-dose GI burden and extend duration of effect, though single-morning dosing is equally effective for most indications.

    At this stage, consider indication-specific customization:

    • Erectile dysfunction: 900-3,000 mg/day KRG (1,000 mg TID is the de Andrade 2007 protocol) for 8-12 weeks. Can be combined with prescription PDE5i (sildenafil, tadalafil) for synergistic effect. Monitor BP for additive hypotension.

    • Cancer-related fatigue: 1,000-2,000 mg/day KRG OR Wisconsin Ginseng 2,000 mg/day for 8-12 weeks (the Barton 2013 protocol). Coordinate with oncologist for use during active treatment.

    • Type 2 diabetes adjunct: 3,000-9,000 mg/day KRG divided TID for 8-12 weeks. Monitor glucose closely — additive hypoglycemia with antidiabetic medications can require dose reduction of prescription drugs.

    • Cognitive performance: 200-400 mg/day G115 (Reay 2010 protocol) for acute and chronic cognitive support. Can be combined with rhodiola for stacked effect.

    • Immune support during cold/flu season: 500-1,500 mg/day KRG daily for 2-4 months during high-infection season (typically October-March in Northern Hemisphere). Particularly valuable for elderly, immune-compromised, healthcare workers, and those with chronic respiratory conditions.

    • General vitality/morning tonic: 500-1,000 mg/day KRG with breakfast, used as ongoing tonic rather than cycled treatment.

    At this dose range, cycling becomes a practical consideration. Traditional Chinese and Korean medicine often recommend 4-weeks-on / 1-week-off or 3-months-on / 1-month-off cycling patterns, though no Western trial has tested cycling versus continuous use. Continuous daily use has been demonstrated safe for 6-12 months in the clinical literature.

    Brand options at intermediate dose:

    • Cheong Kwan Jang Korean Red Ginseng Extract — the definitive KRG extract, available in pouches or capsules, used in many Korean clinical trials
    • Ilhwa Premium Korean Red Ginseng — another Korean premium brand
    • Ginsana G115 — European pharmacy-standard extract
    • NOW Korean Ginseng 500 mg — budget-friendly
    • Nature's Way Korean Ginseng — budget-friendly
    • Solaray Korean Ginseng — mid-tier
    • Life Extension Asian Energy Adapt — combination product with KRG
    • For Panax quinquefolius (American ginseng) for CRF specifically: Wisconsin Ginseng (CW Ginseng), CVT-E002 Cold-fX (immune support), Naturmed American Ginseng
    Advanced

    Advanced Protocol (experienced users, targeted indications):

    Dose range 3,000-9,000 mg/day of Korean Red Ginseng root (or equivalent in standardized extracts, 600-1,200 mg/day G115-equivalent), split TID with meals. This upper range is reserved for:

    • Severe or refractory T2DM (9 g/day protocols, Vuksan 2008 meta-analysis high-dose arm)
    • Severe ED unresponsive to lower doses and PDE5i monotherapy (3 g/day TID, de Andrade 2007 full protocol)
    • Cancer-related severe fatigue unresponsive to 2 g/day (escalate to 3-4 g/day under oncologist supervision)
    • Chronic fatigue syndrome or post-viral fatigue (empirical titration to effect)
    • Age-related vitality decline in elderly (titration based on response and tolerability)

    Advanced-level considerations:

    • Titration: Always titrate upward from 1 g/day to 3 g/day to 6-9 g/day over 4-6 weeks. Abrupt dose escalation increases side effects (insomnia, headache, GI upset) and reduces adherence. Once at high dose, continue for 8-12 weeks before assessing full response.

    • Extract standardization selection: At high dose, extract choice matters. KRG whole root (not extract) at 3-9 g/day provides the most complete ginsenoside spectrum including the red-specific Rg3, Rh2, and Rk1 compounds. High-potency extracts (10-15% ginsenosides, available as "compound K" or "fermented ginseng") provide higher bioavailability per gram but may lack the polysaccharide and volatile components that contribute to the full adaptogenic profile. For most advanced users, KRG whole root at higher doses is preferred over ultra-concentrated extracts.

    • Fermented/compound K products: Pre-fermented ginseng products (Biokan, MetaK, various Korean brands) pre-convert parent ginsenosides to compound K via controlled bacterial fermentation, producing higher bioavailability and more predictable PK. These are relatively new to Western markets and offer an alternative for users with disrupted gut microbiomes (antibiotic exposure, IBD, low-fiber diets) who may have poor conversion of parent ginsenosides to active compound K. 200-400 mg/day of compound K-enriched extract provides effect comparable to 2-4 g/day whole root.

    • Cycling for chronic use: At advanced doses, 4-6 weeks on / 1-2 weeks off cycling may prevent theoretical receptor tolerance and allow periodic reassessment of response. Seasonal rotation (heavy dosing during cold/flu season or demanding work periods, reduced dose or discontinuation during restful periods) is another reasonable approach.

    • Red versus white ginseng at high dose: At 6-9 g/day, the cumulative ginsenoside load is significant, and the choice between red and white ginseng becomes more clinically relevant. Red ginseng has more anti-inflammatory and anti-cancer Rg3/Rh2 content; white ginseng has more stimulating Rg1 content. For T2DM and cancer adjunct use, red ginseng is preferred. For cognitive performance and acute fatigue, white ginseng may be equally effective at lower doses.

    • Drug interaction management: At high dose, drug interactions become clinically meaningful. Warfarin patients need close INR monitoring. Antidiabetic medication patients need close glucose monitoring. Antihypertensive patients need BP monitoring. Immunosuppressed patients should avoid altogether.

    • Discontinuation: Gradual taper over 2-4 weeks if cycling off after extended high-dose use, to allow HPA-axis and cardiovascular system to recalibrate. Abrupt discontinuation after 6-12 months of high-dose use may produce transient fatigue or mild mood effects that resolve within 2-3 weeks.

    • Quality considerations at high dose: At 6-9 g/day, product quality matters more than at typical doses. Adulteration with cheaper ginsenoside-negative roots, pesticide residues, and heavy metal contamination (particularly from Chinese-sourced ginseng not meeting Korean government standards) become proportionately more significant at higher daily intake. Stick with Cheong Kwan Jang, Ilhwa, Ginsana G115, or other premium brands with third-party testing.

    Compare advanced dosing strategies in american ginseng, rhodiola rosea, ashwagandha, and cordyceps.

    Commonly Stacked With

    Panax ginseng stacks are organized around its physical-vitality, metabolic, vasodilatory, and immune-modulatory profile. It differs meaningfully from the cognitive-mood focused adaptogen stacks built around rhodiola, ashwagandha, and bacopa.

    The erectile function stack (KRG + citrulline + arginine + zinc). For ED, particularly mild-to-moderate ED, vasogenic ED, or PDE5i-non-response, combine Korean Red Ginseng 1-3 g/day (900-3,000 mg standardized extract) + l-citrulline 3-6 g/day + l-arginine 3-5 g pre-intimacy + zinc 15-30 mg/day (testosterone cofactor). This targets NO production from multiple angles: KRG upregulates eNOS expression chronically, citrulline provides NO precursor substrate, arginine provides acute substrate, and zinc supports testosterone for libido. The combination is well-tolerated and produces effect sizes approaching low-dose PDE5i in mild ED. For moderate-severe ED, combine with prescription PDE5i (sildenafil, tadalafil) — monitoring for additive hypotension but often producing superior response to either alone.

    The cancer-related fatigue stack (ginseng + CoQ10 + omega-3 + l-carnitine). For cancer patients with treatment-related fatigue (undergoing chemotherapy, radiation, or in survivorship with persistent fatigue), Wisconsin Ginseng (Panax quinquefolius) 2,000 mg/day OR Korean Red Ginseng 1,000-2,000 mg/day + CoQ10 100-300 mg/day (mitochondrial support) + omega-3 EPA/DHA 2,000-3,000 mg/day (anti-inflammatory) + l-carnitine 1-3 g/day (fatty acid oxidation) targets the mitochondrial, inflammatory, and energy-substrate components of cancer-related fatigue. Coordinate with oncologist for ginseng use during active treatment — some oncologists are concerned about antioxidant interference with chemotherapy, though this concern is inconsistent across the evidence.

    The type 2 diabetes adjunct stack (ginseng + berberine + alpha-lipoic acid + chromium + cinnamon). For T2DM or prediabetes not adequately controlled on lifestyle alone (or as adjunct to metformin), Korean Red Ginseng 2-4 g/day + berberine 500 mg BID-TID + alpha-lipoic acid 600-1,200 mg/day + chromium picolinate 200-400 mcg/day + cinnamon 1-3 g/day targets insulin sensitization (ginseng, berberine), glucose uptake (ALA), insulin signaling (chromium), and postprandial glucose (cinnamon). The stack is not a substitute for metformin in diagnosed T2DM but can produce meaningful HbA1c reductions as adjunct. Monitor glucose closely if combining with antidiabetic medications due to additive hypoglycemia risk.

    The immune support stack (ginseng + vitamin D + vitamin C + zinc + elderberry). For cold/flu season, particularly for elderly or immune-compromised individuals, Korean Red Ginseng 500-1,500 mg/day + vitamin D 2,000-5,000 IU/day + vitamin C 500-1,000 mg/day + zinc 15-30 mg/day + elderberry 500-1,000 mg/day during symptoms. Ginseng provides chronic immune-modulatory support (NK cell activation, interferon induction); D3, C, and zinc provide well-established immune cofactors; elderberry provides acute antiviral support during early symptoms.

    The exercise performance stack (ginseng + creatine + beta-alanine + caffeine). For athletes, particularly older athletes or those with chronic fatigue limiting performance, creatine 5 g/day + beta-alanine 3-5 g/day + Korean Red Ginseng 500-1,000 mg pre-training + caffeine 100-200 mg pre-training. Ginseng's contribution is subtle in well-trained rested athletes but meaningful in deconditioned, elderly, or overreached athletes. The mitochondrial and vasodilatory effects provide sustained energy support alongside the acute PCr (creatine), buffering (beta-alanine), and stimulant (caffeine) mechanisms.

    The cognitive-vitality stack (ginseng + rhodiola + bacopa + lion's mane). For broad cognitive and vitality support in knowledge workers, demanding students, or high-achieving professionals, the "big adaptogens" stack combines Panax ginseng 300-600 mg G115 + rhodiola rosea 200-400 mg SHR-5 + bacopa monnieri 300 mg + lion's mane 1,000 mg. Each compound contributes different mechanistic emphasis: ginseng (physical vitality, NO vasodilation, mild cholinergic), rhodiola (acute mental performance, MAO modulation), bacopa (chronic memory consolidation), lion's mane (NGF-mediated neurogenesis). This is a maximalist stack for users wanting comprehensive cognitive and physical support; most users don't need all four.

    The morning/evening split stack (KRG morning + ashwagandha evening). For users wanting physical vitality during the day and stress/sleep support in the evening, Korean Red Ginseng 500-1,000 mg with breakfast + ashwagandha KSM-66 300-600 mg with dinner. The two adaptogens target complementary circadian needs without overlap — ginseng provides morning energy, mental clarity, and vitality; ashwagandha provides evening calm, cortisol suppression, and sleep onset.

    Compounds to avoid stacking with Panax ginseng:

    • Prescription MAO inhibitors (absolute contraindication)
    • High-dose stimulants (amphetamines, high-dose modafinil) — additive sympathetic drive
    • Warfarin without INR monitoring — variable interaction
    • Immunosuppressants in transplant patients — potential immune stimulation

    Compounds with neutral-to-complementary interaction:

    For comparison with related adaptogen stacking logic, see american ginseng, rhodiola rosea, ashwagandha, bacopa monnieri, cordyceps, and eleuthero.

    Side Effects & Safety

    Panax ginseng's side-effect profile at typical clinical doses (1-3 g/day red root or 200-600 mg/day G115-equivalent extract) is favorable, with most adverse events being mild and transient. The compound has been used for thousands of years in traditional Asian medicine without reported chronic toxicity, and the large-N modern clinical trial literature supports the traditional safety experience. **Common side effects (3-8% of users at therapeutic doses):** - Insomnia (3-8%, higher in late-afternoon/evening dosing) — ginseng has mild stimulant-like effects due to its cholinergic and modest norepinephrine-enhancing mechanisms, and afternoon/evening dosing causes sleep disturbance in some users. Solution: morning dosing, ideally before 2 PM. - Headache (3-5%) — often dehydration-related or early-treatment, usually resolves within 1-2 weeks. - GI upset, mild nausea, or loose stools (3-5%) — typically mild, reduced by taking with food. - Skin rash or itching (1-3%) — rare allergic reaction, discontinue if persistent. - Slight blood pressure elevation (1-3%) — modest, typically 2-5 mmHg systolic, usually not clinically significant but worth monitoring in hypertensive patients. - Menstrual irregularities in women (1-3%) — mild changes in cycle length or flow, typically reversible on discontinuation. Reflects phytoestrogen-like activity of some ginsenosides. **Uncommon side effects (1-3%):** - Palpitations or mild tachycardia (1-2%) — additive sympathetic effect, more common at higher doses. - Anxiety or nervousness (1-3%) — typically in anxiety-forward users or those combining with caffeine. Dose reduction or discontinuation resolves. - Mild hypoglycemia in diabetic patients (1-3%) — ginseng lowers blood glucose, additive with antidiabetic medications. Monitor glucose closely when starting. - Facial flushing or warmth (1-2%) — vasodilatory effect, usually transient. - Breast tenderness (1-2% in women) — phytoestrogen effect, reversible. **Rare side effects (<1%):** - Gynecomastia or menstrual irregularities suggesting estrogenic effect — rare, particularly at high chronic doses. - Hepatotoxicity — very rare, with isolated case reports possibly confounded by adulterated products. - Serious allergic reactions — rare, similar to other botanical products. - Mania or hypomania — very rare, possibly in bipolar spectrum patients. - Severe hypertension — rare at therapeutic doses, more common at extreme self-dosing. **The "ginseng abuse syndrome":** Siegel's 1979 description of hypertension, diarrhea, insomnia, nervousness, and skin eruption in 133 chronic ginseng users at high doses (>15 g/day for months) has been widely cited as evidence of ginseng toxicity. Subsequent critical review has noted: (1) many subjects were using adulterated products, (2) dosing was 3-15x typical clinical doses, (3) the syndrome has not been reliably reproduced in controlled studies. At typical therapeutic doses of 1-3 g/day for 4-12 weeks, ginseng abuse syndrome does not occur. **Drug interactions:** - Warfarin — case reports of reduced INR with ginseng, possibly via CYP450 induction or direct effect on warfarin. Monitor INR closely when starting or stopping. - MAO inhibitors (phenelzine, tranylcypromine, selegiline) — theoretical risk of additive sympathetic effects, hypertensive crisis. Avoid combining. - Stimulants (caffeine, amphetamines, modafinil) — additive wakefulness and sympathetic drive. Reduce stimulant dose if combining. - Antidiabetic medications (insulin, sulfonylureas, metformin, GLP-1 agonists) — additive hypoglycemia risk. Monitor glucose closely. - PDE5 inhibitors (sildenafil, tadalafil, vardenafil) — additive NO-mediated vasodilation and hypotension. Generally safe in healthy adults but caution in cardiovascular patients. - Antihypertensive medications — potentially additive or opposing effect (ginseng has both hypertensive and hypotensive effects depending on ginsenoside profile). Monitor BP. - Digoxin — one case report of elevated digoxin levels with ginseng; mechanism unclear. Monitor if combining. - Antiplatelet and anticoagulant drugs — ginseng has mild antiplatelet activity. Monitor for bleeding if combining with aspirin, clopidogrel, warfarin, or DOACs. - Estrogen or hormone replacement therapy — theoretical additive estrogenic effect from some ginsenosides. Monitor. - Immunosuppressants (post-transplant drugs, methotrexate, biologics) — theoretical opposition via ginseng's immune-stimulant activity. Avoid in transplant patients and those on immunosuppression. **Populations requiring caution:** - Bleeding disorders or upcoming surgery — discontinue 1-2 weeks before surgery due to antiplatelet effect - Autoimmune disease — theoretical immune activation concern (SLE, RA, MS, Hashimoto's, Graves', IBD) - Hormone-sensitive cancers (ER+ breast cancer, prostate cancer on hormone therapy) — theoretical phytoestrogen concern, discuss with oncologist - Pregnancy — insufficient safety data, avoid - Breastfeeding — insufficient safety data, avoid - Bipolar disorder — rare reports of mania induction - Uncontrolled hypertension — possible BP elevation - Severe anxiety disorders — stimulant-like effects may worsen - Children under 18 — insufficient pediatric safety data **Contraindicated populations:** - Prescription MAO inhibitors - Active bleeding or coagulopathy - Within 2 weeks of scheduled surgery - Transplant recipients on immunosuppression - Active mania or psychotic depression Compare to the side-effect profile of [rhodiola rosea](/compound/rhodiola-rosea), [ashwagandha](/compound/ashwagandha), [bacopa monnieri](/compound/bacopa-monnieri), and [american ginseng](/compound/american-ginseng).

    Contraindications

    **Absolute contraindications (do not use):** - Prescription MAO inhibitors (phenelzine, tranylcypromine, selegiline, moclobemide, rasagiline, isocarboxazid): theoretical additive sympathetic effects, hypertensive crisis risk. Avoid entirely. Two-week washout required after MAOI before starting ginseng. - Active bleeding or severe coagulopathy - Within 2 weeks of scheduled major surgery (antiplatelet activity) - Transplant recipients on immunosuppression (theoretical immune stimulation could trigger rejection) - Active mania, acute psychotic depression, or severe bipolar instability - Known severe hypersensitivity to Panax species or related Araliaceae plants - Uncontrolled severe hypertension (SBP >180 or DBP >110) - Pregnancy — insufficient safety data, avoid throughout pregnancy - Breastfeeding — insufficient safety data, avoid **Relative contraindications (use with caution and clinician guidance):** - Warfarin therapy — variable interaction, monitor INR closely - Antidiabetic medications (insulin, sulfonylureas, GLP-1 agonists, SGLT2 inhibitors, metformin) — additive hypoglycemia risk, monitor glucose closely - PDE5 inhibitors (sildenafil, tadalafil, vardenafil) — additive vasodilation, monitor BP for hypotension - Antihypertensive medications — variable effect on BP, monitor - Hormone-sensitive cancers (ER+ breast cancer, prostate cancer, ovarian cancer) — theoretical phytoestrogen concern, discuss with oncologist - Active autoimmune disease (SLE, RA, MS, Hashimoto's, Graves', IBD, psoriasis) — theoretical immune activation concern - Bipolar disorder — rare reports of mania induction - Anxiety disorders with hyperarousal — stimulant-like effects may worsen symptoms - Hyperthyroidism — theoretical additive sympathetic effect - Stimulant medications (ADHD meds, decongestants) — additive sympathetic drive - Hormone replacement therapy or birth control — theoretical additive estrogenic effect **Populations requiring clinician oversight:** - Pregnancy and lactation (avoid, no data) - Active cancer treatment (coordinate with oncologist; some oncologists recommend avoiding antioxidants during chemotherapy) - Diabetes on multiple medications (hypoglycemia risk) - Elderly on polypharmacy (drug interaction risk) - Organ transplant recipients - Children under 18 (insufficient pediatric safety data) **Pharmacological red flags during use:** - New-onset insomnia unresponsive to morning-only dosing — reduce dose or discontinue - Significant BP elevation (>20 mmHg systolic rise) — discontinue - Palpitations, chest discomfort, or arrhythmia — discontinue, evaluate - Unexplained bleeding, easy bruising, or menstrual irregularities — discontinue, evaluate coagulation - Hypoglycemic episodes in diabetic patients — reduce ginseng dose or antidiabetic medication dose - Anxiety, agitation, or irritability — reduce dose or discontinue - Mania, hypomania, or psychotic symptoms — immediate discontinuation, psychiatric evaluation - Unexpected hepatic symptoms (jaundice, RUQ pain) — discontinue, evaluate liver function **Legal status:** Panax ginseng is a dietary supplement in the United States (DSHEA-regulated, not FDA-approved for any medical indication), a traditional herbal medicine (THMPD-registered) in the European Union, a classical medicine in China and Korea with government-regulated quality standards (particularly Korean Red Ginseng with KGC oversight), a recognized traditional medicine in Russia, and generally available without prescription worldwide. WADA does not list Panax ginseng as a prohibited substance for athletes in competition. Military personnel should check unit-specific supplement policies. Some countries (Korea, particularly) have government-controlled premium KRG production with strict quality and authenticity requirements.

    Check interactions with the Interaction Checker →

    Additional Notes

    Panax ginseng dosing is best anchored to either raw red root powder (grams per day) or standardized extract (mg of extract with specified ginsenoside percentage). The most-cited clinical doses are 1-3 g/day of Korean Red Ginseng (KRG) root or 200-600 mg/day of G115-equivalent extract (4-5% ginsenosides). Therapeutic dose range across the literature is 500 mg to 9,000 mg/day red root or 100 mg to 1,200 mg/day standardized extract.

    Extract standardization conversions:

    • 1 g KRG whole root ≈ 200-300 mg of 4-5% standardized extract (depends on root ginsenoside content)
    • G115 (4% ginsenosides) 200 mg/day ≈ Ginsana 200 mg/day
    • Compound K-enriched extract 200 mg/day ≈ 2 g KRG whole root/day (bioavailability adjusted)
    • Fermented ginseng 100-200 mg/day ≈ 1-2 g KRG whole root/day

    Timing: Morning dosing, ideally with breakfast, is the standard. Never dose after 2 PM — ginseng has mild stimulant-like effects that disrupt sleep onset in 5-10% of users at typical doses and higher percentages at advanced doses. Users taking ginseng for shift work should dose at the start of their wake period regardless of clock time.

    With or without food: Take with food to improve tolerability and potentially enhance absorption of some ginsenosides. Fasting dosing produces faster subjective onset but slightly higher rates of GI upset.

    Chronic versus cycled use: Both are valid. Continuous daily use has been demonstrated safe for 6-12 months in clinical trials. Traditional Chinese and Korean medicine often recommend 4-weeks-on / 1-week-off cycling, though no Western trial has compared cycling to continuous use. For indications like T2DM or chronic fatigue, continuous use is appropriate. For cold/flu season immune support, seasonal use (October-March) is appropriate.

    Dose-response considerations: The Vuksan T2DM trials showed clear dose-response up to 9 g/day for glucose effects. The ED trials have used 900-3,000 mg/day with similar effect sizes across the range. For cognitive and fatigue indications, effects appear to plateau at 2-3 g/day. For most users, 1-3 g/day KRG or 200-400 mg/day G115 is sufficient; higher doses are reserved for severe or refractory indications.

    Forms and preparations:

    • Whole root (sliced or powdered): traditional form, can be chewed, brewed as tea, or encapsulated. 1-3 g/day typical.
    • Concentrated extract (pouches, capsules, tablets): most convenient, standardized ginsenoside content. 200-600 mg/day typical.
    • Liquid extract (alcoholic tincture): faster onset, variable potency by brand. 1-3 mL TID typical.
    • Tea (decocted from root): traditional preparation, 3-6 g of dried root per day.
    • Honeyed ginseng (traditional Korean preparation): ginseng slices in honey for gradual consumption.
    • Compound K-enriched extract: pre-fermented to active metabolite. 200-400 mg/day equivalent to 2-4 g whole root.

    Red versus white ginseng: Red ginseng (steamed) is the most-studied form in clinical trials and has enhanced Rg3/Rh2/Rk1/Rg5 ginsenosides not present in white (unsteamed) ginseng. For most clinical indications, red is preferred. White ginseng has higher Rg1 content and may be more stimulating/cognitive-focused; it's less well-studied in trials.

    Quality and sourcing: Korean-grown KRG with Korea Ginseng Corporation certification (Cheong Kwan Jang) is the gold standard for quality. Chinese-grown Panax ginseng varies widely in quality — premium grades are excellent, budget grades can be adulterated or contaminated with pesticides. Wisconsin ginseng (actually Panax quinquefolius, see american ginseng) is a different species. Russian-grown ginseng is primarily for export to Asian markets.

    Brand-specific dosing:

    • Cheong Kwan Jang Extract Pouches: 1 pouch/day = equivalent to ~2-3 g KRG root
    • Cheong Kwan Jang Capsules: 500 mg KRG extract/capsule, 2-6/day
    • Ginsana Capsules: 100 mg G115 extract/capsule, 2-4/day
    • NOW Korean Ginseng: 500 mg KRG extract/capsule, 1-3/day
    • Nature's Way Korean Ginseng: 560 mg KRG extract/capsule, 1-3/day
    • Ilhwa Premium KRG: 200 mg KRG extract/capsule, 1-3/day

    Frequently Asked Questions

    What is the recommended Panax ginseng dosage?

    Dosage for Panax ginseng varies by protocol. Consult a qualified healthcare provider.

    How often should I take Panax ginseng?

    Administration frequency depends on the specific protocol. Consult current research literature.

    Does Panax ginseng need to be cycled?

    Cycling requirements depend on the protocol. Follow established research guidelines.

    What are Panax ginseng side effects?

    Panax ginseng's side-effect profile at typical clinical doses (1-3 g/day red root or 200-600 mg/day G115-equivalent extract) is favorable, with most adverse events being mild and transient. The compound has been used for thousands of years in traditional Asian medicine without reported chronic toxicity, and the large-N modern clinical trial literature supports the traditional safety experience. **Common side effects (3-8% of users at therapeutic doses):** - Insomnia (3-8%, higher in late-afternoon/evening dosing) — ginseng has mild stimulant-like effects due to its cholinergic and modest norepinephrine-enhancing mechanisms, and afternoon/evening dosing causes sleep disturbance in some users. Solution: morning dosing, ideally before 2 PM. - Headache (3-5%) — often dehydration-related or early-treatment, usually resolves within 1-2 weeks. - GI upset, mild nausea, or loose stools (3-5%) — typically mild, reduced by taking with food. - Skin rash or itching (1-3%) — rare allergic reaction, discontinue if persistent. - Slight blood pressure elevation (1-3%) — modest, typically 2-5 mmHg systolic, usually not clinically significant but worth monitoring in hypertensive patients. - Menstrual irregularities in women (1-3%) — mild changes in cycle length or flow, typically reversible on discontinuation. Reflects phytoestrogen-like activity of some ginsenosides. **Uncommon side effects (1-3%):** - Palpitations or mild tachycardia (1-2%) — additive sympathetic effect, more common at higher doses. - Anxiety or nervousness (1-3%) — typically in anxiety-forward users or those combining with caffeine. Dose reduction or discontinuation resolves. - Mild hypoglycemia in diabetic patients (1-3%) — ginseng lowers blood glucose, additive with antidiabetic medications. Monitor glucose closely when starting. - Facial flushing or warmth (1-2%) — vasodilatory effect, usually transient. - Breast tenderness (1-2% in women) — phytoestrogen effect, reversible. **Rare side effects (<1%):** - Gynecomastia or menstrual irregularities suggesting estrogenic effect — rare, particularly at high chronic doses. - Hepatotoxicity — very rare, with isolated case reports possibly confounded by adulterated products. - Serious allergic reactions — rare, similar to other botanical products. - Mania or hypomania — very rare, possibly in bipolar spectrum patients. - Severe hypertension — rare at therapeutic doses, more common at extreme self-dosing. **The "ginseng abuse syndrome":** Siegel's 1979 description of hypertension, diarrhea, insomnia, nervousness, and skin eruption in 133 chronic ginseng users at high doses (>15 g/day for months) has been widely cited as evidence of ginseng toxicity. Subsequent critical review has noted: (1) many subjects were using adulterated products, (2) dosing was 3-15x typical clinical doses, (3) the syndrome has not been reliably reproduced in controlled studies. At typical therapeutic doses of 1-3 g/day for 4-12 weeks, ginseng abuse syndrome does not occur. **Drug interactions:** - Warfarin — case reports of reduced INR with ginseng, possibly via CYP450 induction or direct effect on warfarin. Monitor INR closely when starting or stopping. - MAO inhibitors (phenelzine, tranylcypromine, selegiline) — theoretical risk of additive sympathetic effects, hypertensive crisis. Avoid combining. - Stimulants (caffeine, amphetamines, modafinil) — additive wakefulness and sympathetic drive. Reduce stimulant dose if combining. - Antidiabetic medications (insulin, sulfonylureas, metformin, GLP-1 agonists) — additive hypoglycemia risk. Monitor glucose closely. - PDE5 inhibitors (sildenafil, tadalafil, vardenafil) — additive NO-mediated vasodilation and hypotension. Generally safe in healthy adults but caution in cardiovascular patients. - Antihypertensive medications — potentially additive or opposing effect (ginseng has both hypertensive and hypotensive effects depending on ginsenoside profile). Monitor BP. - Digoxin — one case report of elevated digoxin levels with ginseng; mechanism unclear. Monitor if combining. - Antiplatelet and anticoagulant drugs — ginseng has mild antiplatelet activity. Monitor for bleeding if combining with aspirin, clopidogrel, warfarin, or DOACs. - Estrogen or hormone replacement therapy — theoretical additive estrogenic effect from some ginsenosides. Monitor. - Immunosuppressants (post-transplant drugs, methotrexate, biologics) — theoretical opposition via ginseng's immune-stimulant activity. Avoid in transplant patients and those on immunosuppression. **Populations requiring caution:** - Bleeding disorders or upcoming surgery — discontinue 1-2 weeks before surgery due to antiplatelet effect - Autoimmune disease — theoretical immune activation concern (SLE, RA, MS, Hashimoto's, Graves', IBD) - Hormone-sensitive cancers (ER+ breast cancer, prostate cancer on hormone therapy) — theoretical phytoestrogen concern, discuss with oncologist - Pregnancy — insufficient safety data, avoid - Breastfeeding — insufficient safety data, avoid - Bipolar disorder — rare reports of mania induction - Uncontrolled hypertension — possible BP elevation - Severe anxiety disorders — stimulant-like effects may worsen - Children under 18 — insufficient pediatric safety data **Contraindicated populations:** - Prescription MAO inhibitors - Active bleeding or coagulopathy - Within 2 weeks of scheduled surgery - Transplant recipients on immunosuppression - Active mania or psychotic depression Compare to the side-effect profile of [rhodiola rosea](/compound/rhodiola-rosea), [ashwagandha](/compound/ashwagandha), [bacopa monnieri](/compound/bacopa-monnieri), and [american ginseng](/compound/american-ginseng).

    Where can I buy Panax ginseng?

    Visit our vendor directory to find trusted sources for Panax ginseng.

    Free 2026 Peptide Cheat Sheet — 50 pages, PDF

    Dosing, reconstitution, stacks, half-lives, and vendor trust tiers. The reference we wish we had on day one.

    Download Free
    ResearchChemHQ BPC-157 500mcg × 60 capsules bottle
    IN STOCK · COA PER BATCH

    BPC-157 Caps

    60 caps × 500mcg. HPLC + COA on every batch, ≥99% purity. Same molecule as the vials, just oral so it travels. code REDDIT stacks with their 5-vial 20% off and 10-vial 40% off tiers.

    COUPON CODEREDDIT
    Grab a bottle →
    Research use only. Not for human consumption.|BodyHackGuide promotes vendors. We do not sell these products.